Find Your Edge
The practice of sports vision training has evolved due to a better understanding of how the visual system works and new technologies that allow us to access information and train in natural contexts. Dr. Greg Appelbaum, Ph.D., and his team at the Duke University School of Medicine’s Human Performance Optimization Lab, are interested in…
Latest
Find Your Edge
How Dr. Daniel Laby of SportsVision NYC Created a Whole Category of Moneyball for Vision
Do athletes have a sixth sense when it comes to anticipating a penalty kick or deciphering whether to swing at an iffy strike zone pitch? Yes and no — it’s a mix of stellar hand-eye coordination, past experience that helps athletes anticipate the ball, and training. But not simply athletic training; visual-motor reaction time…
Latest
From Queries to Conversations with AI in Marketing Analytics
In this episode of the SparkCast, Aby Varma—founder of Spark Novus, a firm that helps marketing leaders adopt AI responsibly and strategically—sits down with Daniel Kravtsov, CEO and Co-Founder of Improvado. Daniel shares his unique journey from Russia to founding a cutting-edge martech company in the Bay Area. Together, they explore how AI agents…
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…
What’s Next in Preclinical Cancer Immunotherapy Research?
As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…